225 related articles for article (PubMed ID: 16956087)
1. [Galactorrhoea and the use of selective serotonin reuptake inhibitors].
Wessels-van Middendorp AM; Timmerman L
Tijdschr Psychiatr; 2006; 48(3):229-34. PubMed ID: 16956087
[TBL] [Abstract][Full Text] [Related]
2. A case with euprolactinemic galactorrhea induced by escitalopram.
Gulsun M; Algul A; Semiz UB; Ates MA; Doruk A; Ebrinc S; Basoglu C; Cetin M
Int J Psychiatry Med; 2007; 37(3):275-8. PubMed ID: 18314855
[TBL] [Abstract][Full Text] [Related]
3. Trazodone induced galactorrhea: a case report.
Arslan FC; Uysal EK; Ozkorumak E; Tiryaki A
Gen Hosp Psychiatry; 2015; 37(4):373.e1-2. PubMed ID: 25920951
[TBL] [Abstract][Full Text] [Related]
4. Citalopram related euprolactinaemic galactorrhoea: a case report.
Belli H; Vardar MK; Yesilyurt S; Gul ES; Ural C
West Indian Med J; 2010 Jan; 59(1):100-1. PubMed ID: 20931925
[No Abstract] [Full Text] [Related]
5. A case of galactorrhea during paroxetine treatment.
Evrensel A; Önen Ünsalver B; Akyol A; Ceylan ME
Int J Psychiatry Med; 2016 Apr; 51(3):302-5. PubMed ID: 27284122
[TBL] [Abstract][Full Text] [Related]
6. [A clinical case of galactorrhoea after citalopram treatment].
González Pablos E; Mínguez Martín L; Hernández Fernández M; Sanguina Andrés RM
Actas Esp Psiquiatr; 2001; 29(6):414. PubMed ID: 11730581
[No Abstract] [Full Text] [Related]
7. Citalopram-Induced Galactorrhea in an Adolescent.
Türkoğlu S
Clin Neuropharmacol; 2016; 39(6):331. PubMed ID: 27438185
[No Abstract] [Full Text] [Related]
8. Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.
Pratheesh PJ; Praharaj SK; Srivastava A
Psychopharmacol Bull; 2011; 44(1):70-3. PubMed ID: 22506441
[TBL] [Abstract][Full Text] [Related]
9. Reversible galactorrhea and prolactin elevation related to fluoxetine use.
Peterson MC
Mayo Clin Proc; 2001 Feb; 76(2):215-6. PubMed ID: 11213313
[TBL] [Abstract][Full Text] [Related]
10. Sertraline-induced galactorrhea: case report and review of cases reported with other SSRIs.
Nebhinani N
Gen Hosp Psychiatry; 2013; 35(5):576.e3-5. PubMed ID: 23260337
[TBL] [Abstract][Full Text] [Related]
11. From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
Emiliano AB; Fudge JL
Neuropsychopharmacology; 2004 May; 29(5):833-46. PubMed ID: 14997175
[TBL] [Abstract][Full Text] [Related]
12. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
13. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.
Damsa C; Bumb A; Bianchi-Demicheli F; Vidailhet P; Sterck R; Andreoli A; Beyenburg S
J Clin Psychiatry; 2004 Aug; 65(8):1064-8. PubMed ID: 15323590
[TBL] [Abstract][Full Text] [Related]
14. [Duloxetine Associated Galactorrhea and Hyperprolactinemia: A Case Report].
Özkan HM
Turk Psikiyatri Derg; 2020; 31(4):294-296. PubMed ID: 33454942
[TBL] [Abstract][Full Text] [Related]
15. Euprolactinemic galactorrhea associated with use of imipramine and escitalopram in a postmenopausal woman.
Mahasuar R; Majhi P; Ravan JR
Gen Hosp Psychiatry; 2010; 32(3):341.e11-3. PubMed ID: 20430243
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
J Psychopharmacol; ; . PubMed ID: 33637001
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
